March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Highlights by Sakditad Saowapa from ASCO GU25
Feb 16, 2025, 15:59

Highlights by Sakditad Saowapa from ASCO GU25

The 2025 ASCO Genitourinary (GU) Cancers Symposium takes place from February 13 to 15, featuring interactive sessions focused on cutting-edge research, multidisciplinary expertise, and evidence-based practices in GU cancer care. ASCO, the American Society for Radiation Oncology, and the Society of Urologic Oncology cosponsor the symposium.

Highlights by María Natalia Gandur Quiroga from ASCO GU25

Sakditad Saowapa, Resident Physician at Texas Tech University Health Sciences Center, shared some insights the the Symposium:

“Rocking the last day of GU25”

“Ready to rock the last day of GU25!

Let’s make it fun and refreshing at the ASCO Genitourinary Cancers

Symposium for renal cancer day.”

Highlights by Sakditad Saowapa from ASCO GU25

“faster PSA rises increase the chance of true positives”

“PSMA PET scans can be tricky with false positives, but faster PSA rises increase the chance of true positives.

Expected spread patterns usually hold true, and no PSMA agent stands out yet. Standardized reporting helps!”

Highlights by Sakditad Saowapa from ASCO GU25

“PSMA PET vs. Conventional Imaging”

“PSMA PET vs. Conventional Imaging:

PSMA PET offers superior accuracy, sensitivity, and specificity for detecting metastases in high-risk patients in RCT, while 18F-Fluciclovine is approved for biochemical recurrent disease detection, not initial staging.

WB-MRI excels in bone lesion detection but is less sensitive for nodal lesions compared to PSMA imaging.

Case-Based Session: Evolving Landscape of the Management of Oligometastatic Disease (Prostate Cancer).”

Highlights by Sakditad Saowapa from ASCO GU25

“Interesting session on gut health and prostate cancer”

“Super interesting session on gut health and prostate cancer!

Ab311 by Dr. Robert J. Thomas.

Study shows that boosting phytochemical-rich foods with a specific supplement slows PSA progression and improves urinary symptoms.

World’s first robust RCT indicates a lactobacillus supplement further reduces PSA progression.

Exciting findings with longer-term follow-up needed for low-risk men. Self-help nutrition advice welcomed!”

Highlights by Sakditad Saowapa from ASCO GU25

“Driving Science to Improve Patient-Centered Care”

“Creative Innovation: Driving Science to Improve Patient-Centered Care by Bill Dahut starting now!!

At general session 3rd floor Moscone West San Francisco.”

Highlights by Sakditad Saowapa from ASCO GU25

“QOL matters in every decision”

“QOL matters in every decision!

Let’s make treatment choices that keep them smiling.

Great session indeed!”

Highlights by Sakditad Saowapa from ASCO GU25

“Dr. Christopher Wee at GU25”

“Thanks for the great catch-up,

Dr. Christopher Wee from Cleveland Clinic at GU25!

Your support during my medical oncology away rotation and the letter of recommendation for my heme/onc fellowship training were invaluable.

Couldn’t have done it without your help!”

Highlights by Sakditad Saowapa from ASCO GU25

More posts featuring Sakditad Saowapa and ASCO GU25.